Screening for prostate cancer is burdened by a high rate of overdiagnosis. The most appropriate algorithm for population-based screening is unknown. We invited 37,887 men who were 50 to 60 years of ...
A recent BMJ Oncology study screens the prevalence of prostate magnetic resonance imaging (MRI) lesions in men based on age rather than prostate-specific antigen (PSA) levels. Study: Prevalence of MRI ...
Prostate zonal anatomy is best demonstrated with MRI. On T2-weighted sequences, the normal prostate can be divided into the peripheral zone, which shows high signal intensity owing to its high water ...
MRI screening shows promise for predicting clinically significant prostate cancer (PCa) early on and independently of prostate-specific antigen (PSA) assessment. In a recent study published in BMJ ...
In the Jönköping Region of Sweden, PSA measurements were taken for 23,802 men from November 1, 2011, to July 31, 2020, with follow-up concluded on January 31, 2021. Participants were categorized into ...
Prognostic value of circulating tumor DNA for progression-free survival in patients with locally advanced dMMR/MSI-H colorectal cancer managed without surgery. Genomic alterations in circulating tumor ...
Findings address a gap of knowledge highlighted in current guidelines on the use of MRI in the diagnosis and management of prostate cancer. (HealthDay News) — Men with negative multiparametric ...
Confirmatory or systematic prostate biopsies may be unnecessary for men considering active surveillance for prostate cancer who have negative findings on multiparametric MRI scans. Multiparametric MRI ...
MONDAY, Dec. 30, 2024 (HealthDay News) -- Men with negative multiparametric magnetic resonance imaging (mpMRI) results avoiding biopsy do not have an increased risk for clinically significant prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback